Stevenage, United Kingdom

Mark Uden

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Beckenham, GB (2015)
  • Stevenage, GB (2017 - 2023)

Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Mark Uden - Pioneering Inventor Revolutionizing Protein Production

Introduction:

Meet Mark Uden, a visionary inventor hailing from Stevenage, GB, with a remarkable track record in the field of biotechnology. With a total of 8 patents to his name, Mark Uden is at the forefront of groundbreaking innovations in the production of recombinant proteins and antibody variants.

Latest Patents:

Uden's most recent patents showcase his innovative approach to biopharmaceuticals. One notable invention is a method of producing a recombinant protein in a host cell by introducing Polyethyleneimine (PEI) during cell culture. This method not only reduces the viscosity of the cell culture but also enhances the extracellular concentration of the recombinant protein, ultimately streamlining the protein recovery process. Additionally, Uden has developed methods for engineering antibodies with improved bioavailability for subcutaneous administration, catering to the evolving needs of the pharmaceutical industry.

Career Highlights:

Mark Uden has made significant contributions to the field while working at esteemed companies such as GlaxoSmithKline Intellectual Property Development Limited and Glaxo Group Limited. His work at these organizations has been instrumental in driving forward innovation in biopharmaceuticals, earning him a reputation as a trailblazer in his field.

Collaborations:

Throughout his career, Mark Uden has collaborated with industry experts such as Alan Peter Lewis and Ekaterini Kotsopoulou. Together, they have worked on groundbreaking projects that have pushed the boundaries of biotechnology, paving the way for future advancements in the field.

Conclusion:

In conclusion, Mark Uden stands as a driving force in the world of biopharmaceutical innovation. His relentless pursuit of excellence and groundbreaking inventions have not only advanced the field but have also set a new standard for biotechnological research. With a bright future ahead, Mark Uden continues to inspire and shape the landscape of protein production and antibody engineering.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…